.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Healthtrust
Queensland Health
Merck
Cipla
Fuji
McKesson
AstraZeneca
Fish and Richardson
Accenture

Generated: September 22, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Summary for Patent: ► Subscribe

Title:Bone grafts including osteogenic stem cells, and methods relating to the same
Abstract: Bone grafts and constructs including stem cells are provided. Example bone grafts include osteogenic stem cells seeded on a scaffold of osteoconductive cortico-cancellous chips and/or osteoinductive demineralized bone. Example constructs include extracellular matrix on a synthetic scaffold, in which the ECM is secreted from MSCs seeded onto the synthetic scaffold. Also provided are methods of making the present bone grafts and scaffolds. Further provided are methods of promoting bone healing and treating wound healing, by administering the present bone grafts and constructs to a mammal in need thereof. Also provided are kits that include the present bone grafts and/or constructs, or components thereof.
Inventor(s): Bhat; Archana (Royersford, PA), Rao; Shairali (Austin, TX), Laskowitz; Daniel (Lancaster, PA)
Assignee: Globus Medical, Inc. (Audubon, PA)
Application Number:14/057,806
Patent Claims:1. A method of making a bone graft comprising: obtaining bone including condyles, cortical bone, cancellous bone, and bone marrow from a donor; culturing osteogenic stem cells from the cancellous bone, bone marrow, or both by seeding cells onto a tissue culture substrate, allowing the cells to attach, washing the substrate to remove blood cells, and detaching osteogenic stem cells from the substrate; seeding the osteogenic stem cells on a scaffold consisting of osteoinductive demineralized bone obtained from the cortical bone and osteoconductive cortico-cancellous chips obtained from the condyles to form the bone graft, wherein the osteogenic stem cells, demineralized bone, and cortico-cancellous chips are derived from the same donor.

2. The method of claim 1, wherein the osteogenic stem cells are obtained by treating cancellous bone from a femur or tibia with collagenase and separating loosely attached cells by centrifugation.

3. The method of claim 1, wherein the osteogenic stem cells comprise osteogenic cells isolated from bone marrow harvested from an iliac crest.

4. The method of claim 1, wherein the osteogenic stem cells comprise osteogenic cells isolated from adipose tissue.

5. The method of claim 1, further comprising rinsing the scaffold in phosphate buffered saline to remove unwanted cells.

6. The method of claim 1, wherein the scaffold is a mix of demineralized bone and cortico-cancellous chips in a ratio of about 1:1, 1:2 or 1:3.

7. The method of claim 1, wherein the osteogenic stem cells are seeded on the scaffold such that the bone graft has a seeding density of 20,000 to 100,000 cells/cm.sup.2.

8. The method of claim 1, wherein the osteogenic stem cells are mesenchymal stem cells.

9. The method of claim 8, wherein the mesenchymal stem cells are derived from a human source.

10. The method of claim 8, wherein the mesenchymal stem cells are derived from a bovine source.

11. The method of claim 8, wherein the bone graft has a putty-like consistency.

12. A method of making a bone graft having viable cells, the method comprising: obtaining bone including condyles, cortical shaft, cancellous bone, and bone marrow; separating the condyles from the cortical shaft and cancellous bone; treating the cancellous bone with collagenase and separating loose cells by centrifugation; flushing the bone marrow from the cortical shaft and mixing the bone marrow with the loose cells separated by centrifugation to form a mixture of bone marrow and cells; culturing the mixture of bone marrow and cells on a tissue culture substrate and obtaining osteogenic stem cells; milling the condyles to form cortico-cancellous chips; milling and demineralizing the cortical shaft to form demineralized bone matrix; combining the cortico-cancellous chips and demineralized bone matrix to form a scaffold; and seeding the osteogenic stem cells on the scaffold to form the bone graft having viable cells capable of bone regeneration.

13. The method of claim 12, wherein the scaffold consists of a mixture of demineralized bone matrix and cortico-cancellous chips in a ratio of about 1:1.

14. The method of claim 12, wherein the bone is a long bone including one or more of a femur, tibia, and humerus.

15. The method of claim 12, wherein the osteogenic stem cells are seeded on the scaffold such that the bone graft has a seeding density of 20,000 to 100,000 cells/cm.sup.2.

16. The method of claim 12, wherein the osteogenic stem cells are mesenchymal stem cells.

17. The method of claim 16, wherein the mesenchymal stem cells are derived from a human source.

18. The method of claim 12, wherein the bone graft has a putty-like consistency.

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Advance Biofactures
SANTYL
collagenase
VIAL1019950011965-06-04► Subscribe Globus Medical, Inc. (Audubon, PA) Bhat; Archana (Royersford, PA), Rao; Shairali (Austin, TX), Laskowitz; Daniel (Lancaster, PA) ► SubscribeRXsearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Publication Date
United States of America2015110747Apr 23, 2015
United States of America2017072101Mar 16, 2017
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
Queensland Health
Dow
AstraZeneca
Colorcon
Cipla
Covington
UBS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot